NEW YORK ( TheStreet) -- Several stocks trading near or under $5 were poised to move on above-average volume during Friday's trading session.

Novavax ( NVAX) has jumped 8.7% to $2.60 in pre-market trading after the company said that it presented positive clinical results from a study of an H1N1 influenza vaccine at The World Health Organization conference in Geneva, Switzerland. The 50-day average daily volume for Novavax is 1.7 million shares.

RealNetworks ( RNWK) has added 5.1% at $4.80 in pre-market trading after the company said that it released a new version of RealPlayer SP that includes a new trimming feature that allows users to quickly edit their video clips to focus just on the content that they want to keep and share with others. The 50-day average daily volume for RealNetworks is 832,000 shares.

GenVec ( GNVC) advanced 4.3% to $2.40 in pre-market trading after the company said in a statement that it has signed a new contract with the Department of Homeland Security to continue the development of certain vaccines against foot-and-mouth disease. Under this new agreement, GenVec will receive $3.8 million in program funding the first year and an additional $0.7 million if DHS exercises its renewal option under the contract. The 50-day average daily volume for GenVec is 4.6 million shares.

JA Solar ( JASO) fell 4.2% to $5.10 in Friday pre-market trading after a run up over last week. The trigger of the fall was solar sector bellwether First Solar, whose earnings announcement after the market close Thursday caused a pullback in solar shares. The fall was compounded by the Fed decision to raise interest rates, which will weaken the Euro, exposing many solar companies to foreign currency risks; these companies benefit from sales in Europe and a strong euro. The 50-day average daily volume for JA Solar is 10.5 million shares.

-- Reported by Andrea Tse in New York

>>See our new stock quote page.

Follow TheStreet.com on Twitter and become a fan on Facebook.
Copyright 2009 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

If you liked this article you might like

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite

Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese Firm

Biotech Movers: Alexion, Arena, Novavax

Biotech Movers: Pacific Biosciences Shares Lower After Pricing Stock Offering